Fixed dose combinations

Atripla / TLE (efavirenz + tenofovir DF + emtricitabine/lamivudine)

2 February 2025. Related: ARVs, Fixed dose combinations, NNRTIs, Nukes

Generic versions of Atripla (pictured) will look different. It is sometimes called TLE or AF2B.

Generic versions include Atenef, Atreslawin, Atroiza, Citenvir, Heftenam, Odimune, Rizene, Teevir, Trenvir, Tribuss, Triolar, Trivenz, Truno, Trustiva, Viraday and Vonavir.

Full details about Atripla / TLE (efavirenz + tenofovir DF + emtricitabine/lamivudine)

Biktarvy: bictegravir/emtricitabine/TAF

30 August 2024. Related: ARVs, Fixed dose combinations, Integrase inhibitors, Nukes

Biktarvy is a pink/grey film-coated tablet (15 mm x 8 mm) with “GSI” on one side and “9883” on the other.

Full details about Biktarvy: bictegravir/emtricitabine/TAF

doravirine/TDF/3TC FDC (Delstrigo)

18 September 2019. Related: ARVs, Fixed dose combinations, NNRTIs, Nukes

Delstrigo is a light yellow tablet embossed with “776” on one side. (Source: aidsinfo.nih)

Full details about doravirine/TDF/3TC FDC (Delstrigo)

Dovato (dolutegravir + lamivudine)

30 August 2024. Related: ARVs, Fixed dose combinations, Integrase inhibitors, Nukes

Dovato is a white tablet embossed with “SV137”. (Source: aidsinfo.nih)

Full details about Dovato (dolutegravir + lamivudine)

Eviplera (rilpivirine + tenofovir + FTC)

3 May 2013. Related: ARVs, Fixed dose combinations, NNRTIs, Nukes

Full details about Eviplera (rilpivirine + tenofovir + FTC)

Generic ARVs

30 August 2024. Related: ARVs, Fixed dose combinations, Integrase inhibitors, NNRTIs, Nukes, PIs

A generic drug is one that is manufactured by a different pharmaceutical company to the company that invented the medicine.

Full details about Generic ARVs

Genvoya: elvitegravir + cobicistat + emtricitabine + TAF (E/C/F/TAF)

12 April 2016. Related: ARVs, Fixed dose combinations, Integrase inhibitors, Nukes, PK booster

Full details about Genvoya: elvitegravir + cobicistat + emtricitabine + TAF (E/C/F/TAF)

Juluca (dolutegravir + rilpivirine)

12 May 2018. Related: ARVs, Fixed dose combinations, Integrase inhibitors, NNRTIs

Full details about Juluca (dolutegravir + rilpivirine)

Odefsey (rilpivirine + TAF + emtricitabine)

4 January 2022. Related: ARVs, Fixed dose combinations, NNRTIs, Nukes

Full details about Odefsey (rilpivirine + TAF + emtricitabine)

Stribild (elvitegravir + cobicistat + emtricitabine (FTC) + tenofovir DF)

4 January 2022. Related: ARVs, Fixed dose combinations, Integrase inhibitors, Nukes

Full details about Stribild (elvitegravir + cobicistat + emtricitabine (FTC) + tenofovir DF)

Symtuza (darunavir + cobicistat + emtricitabine + TAF)

12 May 2018. Related: ARVs, Fixed dose combinations, Nukes, PIs

Full details about Symtuza (darunavir + cobicistat + emtricitabine + TAF)

TLD or LTD (tenofovir disoproxil, lamivudine, dolutegravir)

1 January 2025. Related: ARVs, Fixed dose combinations, Integrase inhibitors, NNRTIs

Picture not included as there are many different versions.

Full details about TLD or LTD (tenofovir disoproxil, lamivudine, dolutegravir)

TLE (tenofovir DF/lamivudine/efavirenz)

2 February 2025. Related: ARVs, Fixed dose combinations, NNRTIs, Nukes

Please see Atripla.

Full details about TLE (tenofovir DF/lamivudine/efavirenz)

Triumeq (dolutegravir + abacavir + 3TC)

30 August 2024. Related: ARVs, Fixed dose combinations, Integrase inhibitors, Nukes

Full details about Triumeq (dolutegravir + abacavir + 3TC)

Trizivir (AZT + 3TC + abacavir)

26 August 2012. Related: ARVs, Fixed dose combinations, Nukes

Full details about Trizivir (AZT + 3TC + abacavir)